Skip to main content
. 2021 Feb 14;14:33. doi: 10.1186/s13048-021-00783-3

Table 2.

Univariate and multivariate analysis for PFS and OS in all patients with OMC

Progression-free survival Overall survival
Univariate analysis Multivariate analysis Univariate analysis Multivariate analysis
Variables HR (95 % CI) p-value HR (95 % CI) p-value HR (95 % CI) p-value HR (95 % CI) p-value
Age (years)
 ≥51 vs. <51 0.51 (0.17–1.42) 0.20 0.71 (0.20–2.35) 0.57
FIGO stage
 I vs. II, III, IV 0.11 (0.04–0.32) < 0.01 0.12 (0.02–0.61) 0.01 0.06 (0.01–0.22) < 0.01 0.09 (0.01–0.84) 0.04
Residual tumor at PDS
 Optimal vs. Suboptimal 0.17 (0.06–0.50) < 0.01 0.95 (0.20–3.55) 0.94 0.09 (0.02–0.29) < 0.01 0.37 (0.05–1.68) 0.21
Invasive pattern
 Infiltrative invasion vs. Expansile invasion 8.69 (2.37–55.86) < 0.01 9.01 (2.28–61.41) < 0.01 12.52 (2.37-230.59) < 0.01 17.56 (2.58-393.24) < 0.01

Abbreviations: PFS Progression-free survival, OS Overall survival, OMC ovarian mucinous carcinoma, HR hazard ratio, CI confidence interval, PDS primary debulking surgery